Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival-Reference-Cited by-同舟云学术

Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival

Published:2021-05 Issue:5 Volume:41 Page:2697-2709
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

ORSARIA PAOLO,GRASSO ANTONELLA,IPPOLITO EDY,PANTANO FRANCESCO,SAMMARRA MATTEO,ALTOMARE CARLO,CAGLI BARBARA,COSTA FABIO,PERRONE GIUSEPPE,SOPONARU GEORGETA,CAGGIATI LORENZA,VANNI GIANLUCA,BUONOMO ORESTE CLAUDIO,ALTOMARE VITTORIO

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing treatment sequence for inoperable locally advanced breast cancer: Long‐term outcomes of surgery first versus neoadjuvant chemotherapy in a real‐world setting;International Journal of Cancer;2024-08-23

2. Factors Affecting Pathological Complete Response in Locally Advanced Breast Cancer Cases Receiving Neoadjuvant Therapy: A Comprehensive Literature Review;European Journal of Breast Health;2024-01-01

3. Research Progress on Prognostic Indicators of Neoadjuvant Therapy for HER-2 Positive Breast Cancer;Advances in Clinical Medicine;2024

4. Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study;Frontiers in Oncology;2023-10-02

5. Development and External Validation of 18F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer;Cancers;2023-07-28